Article
Loss of LafB activity reverses daptomycin resistance in E. faecium.
mBio - 14 Jan 2026
Scarpa de Mello Suelen, Schultz Bailey, Goh Byoungsook, Grote Alexandra, Shea Terrance, Muscato Jacob, Oh Sungwhan F, Manson Abigail L, Earl Ashlee M, Walker Suzanne, Camargo Ilana L B C, Gilmore Michael S
Abstract excerpt
Infections caused by multidrug-resistant enterococci, particularly vancomycin-resistant Enterococcus (VRE), present significant therapeutic challenges. Daptomycin, a last-line treatment for VRE, often loses efficacy due to the emergence of resistance. In this study, we revealed the critical role of the lafB gene as a key determinant of daptomycin susceptibility and resistance in E. faecium. We showed that in the...
Topics
Join the communities discussing this publication.
